Jing Su

ORCID: 0000-0003-4917-6173
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Research Studies
  • Brain Metastases and Treatment
  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Single-cell and spatial transcriptomics
  • Glioma Diagnosis and Treatment
  • Gene expression and cancer classification
  • Bioinformatics and Genomic Networks
  • Immune cells in cancer
  • Multiple Myeloma Research and Treatments
  • Cancer Genomics and Diagnostics
  • Mathematical Biology Tumor Growth
  • Cell Image Analysis Techniques
  • Computational Drug Discovery Methods
  • Ferroptosis and cancer prognosis
  • 3D Printing in Biomedical Research
  • Cellular Mechanics and Interactions
  • Metabolomics and Mass Spectrometry Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Gene Regulatory Network Analysis
  • Dementia and Cognitive Impairment Research
  • Lung Cancer Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Receptor Mechanisms and Signaling
  • Chronic Kidney Disease and Diabetes

Indiana University – Purdue University Indianapolis
2020-2025

Indiana University School of Medicine
2020-2025

Hubei Normal University
2025

Quanzhou Normal University
2025

Wake Forest University
2015-2024

Indiana University
2022-2024

Hebei Medical University
2022-2024

Fourth Hospital of Hebei Medical University
2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2017-2024

Shanghai Jiao Tong University
2008-2023

N6-methyladenosine (m6A) modification of mRNA is emerging as a vital mechanism regulating RNA function. Here, we show that fragile X mental retardation protein (FMRP) reads m6A to promote nuclear export methylated targets during neural differentiation. Fmr1 knockout (KO) mice delayed progenitor cell cycle progression and extended maintenance proliferating progenitors into postnatal stages, phenocopying methyltransferase Mettl14 conditional KO (cKO) have no modification. RNA-seq m6A-seq...

10.1016/j.celrep.2019.06.072 article EN cc-by-nc-nd Cell Reports 2019-07-01

Mounting evidence supports a role for the immune system in breast cancer outcomes. The ability to distinguish highly immunogenic tumors susceptible anti-tumor immunity from weakly or inherently immune-resistant would guide development of therapeutic strategies cancer. Genomic, transcriptomic and clinical data Cancer Genome Atlas (TCGA) Molecular Taxonomy Breast International Consortium (METABRIC) cohorts were used examine statistical associations between tumor mutational burden (TMB)...

10.1080/2162402x.2018.1490854 article EN OncoImmunology 2018-07-30
Tellen D. Bennett Richard A. Moffitt Janos Hajagos Benjamin Amor Adit Anand and 95 more Mark M. Bissell Katie R. Bradwell Carolyn Bremer James Brian Byrd Alina Denham Peter E. DeWitt Davera Gabriel Brian T. Garibaldi Andrew T. Girvin Justin Guinney Elaine Hill Stephanie Hong Hunter Jimenez Ramakanth Kavuluru Kristin Kostka Harold P. Lehmann Eli B. Levitt Sandeep K. Mallipattu Amin Manna Julie A. McMurry Michele Morris John Muschelli Andrew J. Neumann Matvey B. Palchuk Emily Pfaff Zhenglong Qian Nabeel Qureshi Seth Russell Heidi Spratt Anita Walden Andrew E. Williams Jacob T. Wooldridge Yun Jae Yoo Xiaohan Tanner Zhang Richard L. Zhu Christopher P. Austin Joel Saltz Kenneth Gersing Melissa Haendel Christopher G. Chute Joel Gagnier Siqing Hu Kanchan Lota Sarah E. Maidlow David A. Hanauer Kevin J. Weatherwax Nikhila Gandrakota Rishikesan Kamaleswaran Greg S. Martin Jingjing Qian Jason E. Farley Patricia A. Francis Dazhi Jiao Hadi Kharrazi Justin Reese Mariam Deacy Usman Ullah Sheikh Jake Y. Chen Michael Quinn Patton T. Bennett Ramsey Jasvinder A. Singh James J. Cimino Jing Su William G. Adams Timothy Q. Duong John B. Buse Jessica Y. Islam Jihad S. Obeid Stéphane M. Meystre Steve Patterson Misha Zemmel Ron Grider A. Pérez Martínez Carlos Antônio do Nascimento Santos Julian Solway Ryan G. Chiu Gerald B. Brown Jia-Feng Cui Sharon X. Liang Kamil Khanipov Jeremy Richard Harper Peter J. Embí David Eichmann Boyd M. Knosp William B. Hillegass Chunlei Wu James R. Aaron Darren W. Henderson Muhammad Gul Tamela Harper Daniel R. Harris Jeffery Talbert Neil Bahroos Steven M. Dubinett Jomol Mathew

The National COVID Cohort Collaborative (N3C) is a centralized, harmonized, high-granularity electronic health record repository that the largest, most representative COVID-19 cohort to date. This multicenter data set can support robust evidence-based development of predictive and diagnostic tools inform clinical care policy.

10.1001/jamanetworkopen.2021.16901 article EN cc-by-nc-nd JAMA Network Open 2021-07-13

Recent development of spatial transcriptomics (ST) is capable associating information at different spots in the tissue section with RNA abundance cells within each spot, which particularly important to understand cytoarchitectures and functions. However, for such ST data, since a spot usually larger than an individual cell, gene expressions measured are from mixture heterogenous cell types. Therefore, data needs be disentangled so as reveal compositions that spot. In this study, we propose...

10.1093/bib/bbaa414 article EN cc-by-nc Briefings in Bioinformatics 2020-12-18

Variation in risk of adverse clinical outcomes patients with cancer and COVID-19 has been reported from relatively small cohorts. The NCATS' National COVID Cohort Collaborative (N3C) is a centralized data resource representing the largest multicenter cohort cases controls nationwide. We aimed to construct characterize within N3C identify factors for all-cause mortality COVID-19.

10.1200/jco.21.01074 article EN Journal of Clinical Oncology 2021-06-04

To provide real-world evidence on risks and outcomes of breakthrough COVID-19 infections in vaccinated patients with cancer using the largest national cohort cases controls.

10.1200/jco.21.02419 article EN cc-by Journal of Clinical Oncology 2022-03-14

Abstract Single-cell omics is the fastest-growing type of genomics data in literature and public repositories. Leveraging growing repository labeled datasets transferring labels from existing to newly generated will empower exploration single-cell data. However, current label transfer methods have limited performance, largely due intrinsic heterogeneity among cell populations extrinsic differences between datasets. Here, we present a robust graph artificial intelligence model, Graph...

10.1038/s41467-021-24172-y article EN cc-by Nature Communications 2021-06-22

Abstract Cell–cell communications are vital for biological signalling and play important roles in complex diseases. Recent advances single-cell spatial transcriptomics (SCST) technologies allow examining the cell communication landscapes hold promise disentangling ligand–receptor (L–R) interactions across cells. However, due to frequent dropout events noisy signals SCST data, it is challenging lack of effective tailored methods accurately infer cellular communications. Herein, decipher...

10.1093/bib/bbac563 article EN cc-by-nc Briefings in Bioinformatics 2022-11-21

Abstract Recent advances in high-throughput molecular imaging have pushed spatial transcriptomics technologies to subcellular resolution, which surpasses the limitations of both single-cell RNA-seq and array-based profiling. The multichannel immunohistochemistry images such data provide rich information on cell types, functions, morphologies cellular compartments. In this work, we developed a method, elucidation through image-augmented Graph transformer (SiGra), leverage for revealing...

10.1038/s41467-023-41437-w article EN cc-by Nature Communications 2023-09-12

Abstract Brain metastases is the most common intracranial tumor and account for approximately 20% of all systematic cancer cases. It a leading cause death in advanced-stage cancer, resulting five-year overall survival rate below 10%. Therefore, there critical need to identify effective biomarkers that can support frequent surveillance promote efficient drug guidance brain metastasis. Recently, remarkable breakthroughs single-cell RNA-sequencing (scRNA-seq) technology have advanced our...

10.1038/s42003-023-05124-2 article EN cc-by Communications Biology 2023-07-21

The Library of Integrated Network-based Cellular Signatures (LINCS) L1000 big data provide gene expression profiles induced by over 10 000 compounds, shRNAs, and kinase inhibitors using the platform.

10.1039/c4mb00677a article EN Molecular BioSystems 2015-01-01

Abstract Background The effect of immunotherapy on brain metastasis patients remains incompletely understood. Our goal was to evaluate its survival, neurologic death, and patterns failure after stereotactic radiosurgery (SRS) without prior whole-brain radiation therapy (WBRT) in with lung melanoma primaries metastatic the brain. Methods We performed a retrospective analysis 271 consecutive or treated upfront SRS for metastases between 2013 2018. Of these patients, 101 (37%) received 170...

10.1093/nop/npz004 article EN Neuro-Oncology Practice 2019-02-05

Unravelling the regulatory programs from single-cell multi-omics data has long been one of major challenges in genomics, especially current emerging field. Currently there is a huge gap between fast-growing and effective methods for integrative analysis these inherent sparse heterogeneous data. In this study, we have developed novel method, Single-cell Multi-omics Gene co-Regulatory algorithm (SMGR), to detect coherent functional signals target genes joint RNA-sequencing (scRNA-seq) assay...

10.1093/nargab/lqac056 article EN cc-by-nc NAR Genomics and Bioinformatics 2022-07-09

Abstract Spatial cellular authors heterogeneity contributes to differential drug responses in a tumor lesion and potential therapeutic resistance. Recent emerging spatial technologies such as CosMx, MERSCOPE Xenium delineate the gene expression patterns at single cell resolution. This provides unprecedented opportunities identify spatially localized resistance optimize treatment for individual patients. In this work, we present graph-based domain adaptation model, SpaRx, reveal of response...

10.1093/bib/bbad338 article EN cc-by-nc Briefings in Bioinformatics 2023-09-11

The clinical value of 3D printed surgical guides in resection and reconstruction malignant bone tumor around the knee joint were studied. For this purpose, a sample 66 patients from October 2013 to 2015 randomly selected further divided into control group observation group, each consisted 33 cases. was treated by conventional whereas, resected with guide. However, tumor-type hinge prosthesis performed both groups then effect compared. Results show that there no significant difference...

10.3892/ol.2017.6749 article EN Oncology Letters 2017-08-11

Multiple myeloma, the second most common hematological cancer, is currently incurable due to refractory disease relapse and development of multiple drug resistance. We others recently established biophysical model that myeloma initiating (stem) cells (MICs) trigger stiffening their niches via SDF-1/CXCR4 paracrine; The stiffened then promote colonogenesis MICs protect them from treatment. In this work we examined in silico pharmaceutical potential targeting MIC niche stiffness facilitate...

10.1371/journal.pone.0085059 article EN cc-by PLoS ONE 2014-01-27

Abstract Immuno-oncology (IO) therapies have transformed the therapeutic landscape of non-small cell lung cancer (NSCLC). However, patient responses to IO are variable and influenced by a heterogeneous combination health, immune, tumor factors. There is pressing need discover distinct NSCLC subgroups that influence response. We developed dee p pa tient graph convolutional n etwork, we call “DeePaN”, complexity across data modalities impacting benefit. DeePaN employs high-dimensional derived...

10.1038/s41746-021-00381-z article EN cc-by npj Digital Medicine 2021-02-02

PurposeMelanoma brain metastases (MBM) occur in ∼50% of melanoma patients. Although both radiation therapy (RT) and immune checkpoint inhibitor (ICI) are used alone or combination for MBM treatment, the role this how these treatments could best be sequenced remains unclear.Methods MaterialsWe conducted a retrospective analysis patients with resected who underwent treatment RT, ICI, RT ICI. Among latter, we specifically investigated differential gene expression via RNA-sequencing between...

10.1016/j.ijrobp.2020.01.043 article EN cc-by-nc-nd International Journal of Radiation Oncology*Biology*Physics 2020-02-11

The incidence of brain metastasis continues to increase as therapeutic strategies have improved for a number solid tumors. presence is associated with worse prognosis but it unclear if distinctive biomarkers can separate patients at risk CNS related death.We executed single institution retrospective collection from who were diagnosed lung, breast, and other primary metastatic samples sent RNA sequencing, proteomic metabolomic analysis metastasis. outcome was distant failure after definitive...

10.3389/fonc.2020.615472 article EN cc-by Frontiers in Oncology 2021-04-06
Coming Soon ...